Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Viking Therapeutics Inc (VKTX)

408 + Investors. Track Smart Money conviction in VKTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -19
Streak
1Q ▼
Buyers last Q
52%

Smart Money Signals — VKTX

Based on 409 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their VKTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (96% of max)

96% of all-time peak
409 hedge funds hold VKTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +10% more funds vs a year ago

fund count last 6Q
+37 new funds entered over the past year (+10% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 52% buying

229 buying208 selling
Last quarter: 229 funds bought or added vs 208 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-48 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 81 → 47 → 112 → 64. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

41% of holders stayed for 2+ years

■ 41% conviction (2yr+) ■ 34% medium ■ 24% new
169 out of 409 hedge funds have held VKTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -1%, value -18%

Value
-18%
Shares
0%
Last quarter: funds added -1% more shares while total portfolio value only changed -18%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

69 → 81 → 47 → 112 → 64 new funds/Q
New funds entering each quarter: 81 → 47 → 112 → 64. A growing number of institutions are discovering VKTX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 44% veterans vs 29% newcomers

■ 44% veterans ■ 27% 1-2yr ■ 29% new
Entry-cohort mix of 434 holders: 191 (44%) are 2+ year veterans, 116 entered 1–2 years ago, and 127 (29%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 43% AUM from top-100 funds

43% from top-100 AUM funds
49 of 405 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in VKTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — VKTX

In 2026 Q1, 229 hedge funds were net buyers of VKTX (64 opened a new position, 165 added to an existing one), while 208 reduced or exited (125 trimmed, 83 sold completely) — a 52% buyer ratio, indicating a slight buying edge. 43% of total institutional value in VKTX is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -19 funds (more exits than new entries). Total institutional holders: 409.

Hedge Fund Ownership: VKTX

How many hedge funds hold VKTX — quarterly history vs. share price
Quarterly hedge fund ownership of VKTX vs. share price

Market Analysis: VKTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: VKTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Viking Therapeutics Inc (VKTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much VKTX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 75d ago
VKTX
-11.6%
XLV
+4.9%

VKTX outperformed XLV by -16.5% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 30d ago
VKTX
-5.0%
XLV
+6.0%

Since the filing became public, VKTX outperformed XLV by -11.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

31 top-rated funds 1 high-conviction
Consensus
6.5
/ 10
breadth
×
Elite
2.3
/ 10
conviction
Hedge Fund Positioning: VKTX
408 + Investors

Track Smart Money conviction in VKTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 408 428 -4.67%
13F Shares 83M 84M -0.88%
Total Value $2.74B $3.36B -18.48%
New Positions 64 112 -48
Increased Positions 151 119 +32
Closed Positions 84 50 +34
Reduced Positions 120 132 -12
Total Calls 19 28 -32.14%
Total Puts 10 12 -16.67%
PUT/CALL Ratio 0.53 0.43 Bullish

Statistics: VKTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

408 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in VKTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 VKTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Act Capital Management, LLC 5.35% 209,300 $6.8M
2 Diadema Partners LP 3.65% 659,200 $21.5M
3 First Washington CORP 3.55% 385,366 $12.5M
4 Diadema Partners LP 2.91% 525,181 $17.1M
5 Mh & Associates Securities Management Corp /Adv 1.86% 65,422 $2.1M
6 BlackBarn Capital Partners LP 1.63% 621,450 $20.2M
7 Persistent Asset Partners Ltd 1.61% 133,066 $4.3M
8 Artia Global Partners LP 1.18% 180,731 $5.9M
9 Quantum Private Wealth, LLC 1.06% 105,135 $3.4M
10 Lewis Asset Management, LLC 0.85% 64,090 $2.1M
11 Vestal Point Capital, LP 0.83% 914,147 $29.7M
12 Tang Capital Management LLC 0.83% 500,000 $16.3M
13 PFM Health Sciences, LP 0.78% 263,106 $8.6M
14 Channel Wealth LLC 0.77% 97,957 $3.2M
15 Rhenman & Partners Asset Management AB 0.64% 160,000 $5.2M
16 Monimus Capital Management, LP 0.61% 67,841 $2.2M
17 Diametric Capital, LP 0.54% 63,896 $2.1M
18 Granahan Investment Management, LLC 0.52% 332,192 $10.8M
19 1492 Capital Management LLC 0.51% 41,181 $1.3M
20 MN Wealth Advisors, LLC 0.50% 31,532 $1.0M
21 Kintayl Capital LP 0.50% 29,273 $953K
22 DAFNA Capital Management LLC 0.44% 59,516 $1.9M
23 ADAR1 Capital Management, LLC 0.44% 227,717 $7.4M
24 Englebert Financial Advisers, LLC 0.44% 11,773 $383K
25 Eversept Partners, LP 0.41% 239,110 $7.8M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Viking Therapeutics Inc (VKTX)

What does the Smart Money Trend signal show for VKTX?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their VKTX positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for VKTX?

Slight buying edge — 52% buying: Last quarter: 229 funds bought or added vs 208 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for VKTX holders?

Elite ownership — 43% AUM from top-100 funds: 49 of 405 holders are among the 100 largest funds by AUM, controlling 43% of total institutional value in VKTX. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held VKTX?

41% of holders stayed for 2+ years: 169 out of 409 hedge funds have held VKTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Viking Therapeutics Inc (VKTX) following the 2026 Q1 hedge fund 13F filings?

As of today, VKTX has moved -5.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to +6.0% for the XLV sector ETF — an outperformance of -11.0%. Since the quarter end (March 31, 2026), VKTX has gained -11.6% vs +4.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →